Its downstream effectors, such as NF-κB, interact with androgen receptor signaling, enabling tumor cell survival and proliferation even under androgen-deprived conditions, thereby advancing the development of castration-resistant prostate cancer (18). Here, NFKB1 is linked to prostate carcinoma.